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Androgenetic alopecia (AGA, male pattern baldness) is the most common form of hair loss. The origin of AGA is genetic, with the X
chromosome located androgen receptor gene (AR) being the only risk gene identiﬁed to date. We present the results of a genome-
wide linkage study of 95 families and linkage ﬁne mapping of the 3q21-q29, 11q14-q25, 18p11-q23, and 19p13-q13 regions in an
extended sample of 125 families of German descent. The locus with strongest evidence for linkage was mapped to 3q26 with a nonpara-
metric linkage (NPL) score of 3.97 (empirical p value¼ 0.00055). This is the ﬁrst step toward the identiﬁcation of new susceptibility genes
in AGA, a process which will provide important insights into the molecular and cellular basis of scalp hair loss.Androgenetic alopecia (AGA [MIM 109200]), or male
pattern baldness, is a progressive patterned loss of hair
from the scalp.1 The proportion of affected males increases
steadily with age, so that a white 70-year-old male has
an 80% chance of having some degree of AGA.1,2 Associa-
tion of AGAwith a variety of diseases has been reported, in-
cluding coronary heart disease,3–5 hypertension,6 benign
prostatic hyperplasia,7 obesity,8 prostate cancer,9,10 anddis-
orders associated with insulin resistance.11,12 Although
some associations remain controversial,13,14 the reported
comorbidities underscore the value of understanding the
molecular basis of AGA. Genetic disposition, which is as-
sumed to be polygenic, plays the most substantial role in
the development of AGA,15–18 and it is therefore surprising
that no systematic approach has yet been undertaken to
identify the contributing genes.Here,wepresent the results
of a genome-wide linkage scan for AGA susceptibility loci in
German families and a subsequent ﬁne-mapping analysis
of the four best linkage regions.
The genome scan was performed on 95 families where at
least two brothers had early-onset AGA and both parents
were available for the study (391 genotyped individuals
including 201 affected men; 86 affected pairs of brothers,
seven affected triplets, two affected quadruplets). All af-
fected males were under 40 years of age (mean5 standard
deviation [SD] age [in years] 32.0 5 5.2) and had an AGA
representative of the most severely affected 10% for the
respective age class, as based on the classiﬁcation of Ham-
ilton,1 modiﬁed by Norwood.19 We collected ethylenedia-
minetetraacetic acid (EDTA) anticoagulated venous blood
samples from all individuals, and isolated lymphocyteDNA by salting out procedure with saturated NaCl solu-
tion.20 The study was approved by the relevant ethics
committees, and written informed consent was obtained
from all participating individuals. All participants were of
German descent.
The genome scan was conducted with procedures
described by Lee and colleagues.21 The 391 DNA samples
were genotyped for 540 autosomal and 37 X chromosomal
short tandem repeat (STR) markers, with an average in-
termarker distance of 6.5 cM for the autosomes and 5.1
cM for the X chromosome (integrated Duffy’s map).22 An
average heterozygosity of 0.77 was observed. Data was
cleaned with graphical representation of relationship
errors (GRR)23 and PEDCHECK.24 Allele frequencies were
estimated by a maximum-likelihood procedure with the
program MENDEL v5.7.25 Single markers immediately
ﬂanked by a recombination on each side were identiﬁed
with the ALLEGRO software, version 1.2,26 and genotypes
were removed. Nonparametric linkage (NPL) analysis of
the genome scan data was performed with the ALLEGRO
software.
The genome-wide linkage analysis revealed nominal
evidence of linkage (p < 0.05) to 14 chromosomal regions:
1q31-q32, 3q21-q27, 5p13-p15, 7q36, 8q13-q21, 8q24,
10p12-p14, 11q14-q24, 14q11, 16p12-p13, 18p11-q22,
19p13-q13, 21q21-q22, and Xp11-q25 (Table 1 and Fig-
ure 1). Xp11-q25 contains the AR gene, which has been
shown to be associated with AGA27,28 and which can be
considered the ﬁrst known AGA gene. Four autosomal re-
gions contained NPL scores greater than 2: 3q26 (NPL ¼
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Table 1. Genome-wide Multipoint NPL Analysis, Regions with Nominal p Values Less than 0.05
Chromosomal
Region
Genomic
Linkage
Intervala [cM]b
Flanking STRs of Interval
(NPL Score)
STR with Lowest p Value
Name Position [cM]b NPL Score p Value
1q31-q32 199.8–213.5 D1S518(1.6)–D1S1678(1.89) D1S1660 207.3 1.9 0.029
3q21-q27 131.8–201 D3S1267(1.3)–D3S3686(1.34) D3S3053 177.4 2.69 0.0035
5p13-p15 15.9–64.9 D5S2505(1.33)–D5S1457(1.21) D5S1991 34.4 1.71 0.0349
7q36 168.1–182.3 D7S3070(1.09)–D7S559(1.16) D7S3058 176.4 1.65 0.0438
8q13-q21 81.4–99.7 D8S1136(1.45)–D8S1119(1.76) D8S1119 99.7 1.76 0.0396
8q24 151.1–157.2 D8S256(1.24)–D8S272(1.94) D8S272 157.2 1.94 0.0264
10p12-p14 19–43.1 D10S189(1.31)–D10S1423(1.09) D10S674 39.3 1.76 0.0398
11q14-q24 94.8–135.5 D11S2632(1.01)–D11S4464(1.56) D11S898 109.2 2.11 0.017
14q11 1.1–6.7 D14S261(1.90)–D14S742(1.34) D14S261 1.1 1.9 0.0291
16p12-p13 30.7–48 D16S748(1.08)–D16S403(1.12) D16S3036 43.4 1.7 0.0452
18p11-q22 14.61–93.1 D18S976(1.01)–D18S1364(1.49) D18S1104 44.6 2.56 0.0053
19p13-q13 20–93.7 D19S1034(2.06)–D19S589(1.79) D19S1034 20 2.06 0.0199
21q21-q22 7.2–45.2 D21S1432(1.47)–D21S1440(1.02) D21S1437 16.5 1.9 0.0293
Xp11-q25 72.6–124.7 DXS1003(1.01)–GATA165B12(1.75) DXS8067 122.3 2.67 0.0039
a With NPL score greater than 1.
b Duffy’s integrated map.18q11 (NPL ¼ 2.56 at 44.6 cM), and 19p13 (NPL ¼ 2.06 at
20 cM).
To deﬁne the chromosomal regions for the ﬁne-mapping
linkage study, we applied a MOD-score analysis to the four
autosomes with NPL scores greater than 2. In this, the para-
metric LOD score is maximized with respect to the trait-
model parameters. We used the program GENEHUNTER-
MODSCORE,29 which calculates MOD scores by varying
thedisease-allele frequencyandpenetrances.Weperformed
the analysis with a starting model of 0.08 for susceptibil-
ity allele frequency and the penetrances of 0.001, 0.5,
and 0.99. The procedure yields the MOD score in conjunc-
tion with the best-ﬁtting penetrance and disease-allele
frequency at each genetic position of a prespeciﬁed grid.
The parameters can be considered an effect estimate for
the particular locus. The MOD-score analysis further sup-
ported the ﬁndings of the nonparametric analysis with
LOD scores of 3.4 on 3q26, 2.5 on 11q22, 2.7 on 18q11,
and 2.4 on 19p13 (Figure 2).
Forﬁne-mapping analysis, theborders of the regionswere
deﬁned by a LOD score greater than 1. A total of 169 STR
markers located within these regions were analyzed by de-
CODEGenetics,withprocedures described elsewhere.30 Be-
cause of the use of pre-establishedmarker panels, these STR
markers included eightmarkers that had been includedpre-
viously in the genome-wide scan. Including all genome-
scanmarkers located in theﬁne-mapping regions, thedistri-
bution of STRs was as follows: chromosome 3q21-q29,
interval D3S1269–D3S3550 (132.9–227 cM), 71 STRs, aver-
age intermarker distance 1.3 cM; chromosome 11q14-q25,
interval D11S4147–D11S4125 (95.4–160.3 cM), 29 STRs,
average intermarker distance 2.3 cM; chromosome 18p11-
q23, interval D18S344–D18S70 (16–124.7 cM), 76 STRs,
average intermarker distance 1.4 cM; chromosome 19p13-
q13, interval D19S247–D19S544 (9.9–107.2 cM), 43 STRs,
average intermarker distance 2.3 cM. One hundred
twenty-ﬁve families, including the 95 families from the738 The American Journal of Human Genetics 82, 737–743, March 2genome-wide study, were used for the ﬁne-mapping study.
The extended-family sample consistedof 516genotyped in-
dividuals with 265 affectedmen in the younger generation.
Data were analyzed according to the nonparametric ge-
nome-scan procedure. To determine robustness of themax-
imumNPL scores obtained with the ﬁne-mapping data, we
performed systematic simulations under the null hypothe-
sis of no linkage. We generated 10,000 replicates with
MERLIN, version 1.1-alpha3.31 Each replicatewas generated
under the assumption of random segregation, with iden-
tical pedigree structure, affection status, marker spacing,
allele frequencies, and patterns of the missing data in the
real data set. Each replicate was analyzed with MERLIN
with computation of the Zmean score, which is equivalent
to theNPL score inALLEGRO.Theempirical pvaluewas cal-
culated as the portion of all replicates showing anNPL score
equal to or higher than the one observed in the real data set.
The results of the ﬁne mapping are shown in Figure 3,
and the STR markers with the highest NPL scores are listed
in Table 2. On chromosome 3q21-q27, the inclusion of 55
additional STR markers in the analysis (compared to the
genome-scan marker set) gave further support to this
region with an NPL score of 3.14 (nominal p value ¼
0.0004, D3S1556) in the 95 families of the genome scan.
This NPL score rose to 3.97 (nominal p value ¼ 0.00003,
D3S2425) when 30 families were added to the analysis (ex-
tended-family set), an observation supporting this as a true
region of linkage. In the other ﬁne-mapping regions, the
addition of markers and families had only a small effect
or even led to a decrease of NPL scores: In chromosomal re-
gion 11q22-q24, the addition of 21 STRs resulted in an NPL
score of 2.55 (nominal p value ¼ 0.0055, D11S1891) in 95
families and 1.87 (nominal p value ¼ 0.0311, D11S1891)
in 125 families; on chromosome 18p11-q22, the addition
of 57 STRs resulted in an NPL score of 2.47 (nominal p
value¼ 0.0068, D18S877) in 95 families and 1.97 (nominal
p value ¼ 0.0244, D18S1104) in 125 families; on008
Figure 1. Genome-wide Linkage Analysis of 95 Families with Early-Onset AGA
The multipoint NPL score is shown on the vertical axis, and the distance (in cM, Duffy’s integrated map) is given on the horizontal axis.chromosome 19p13-q13, the addition of 28 STRs re-
sulted in an NPL score of 1.93 (nominal p value ¼
0.0273, D19S1034) and 2.19 (nominal p value ¼
0.0143, D19S921) in 95 families and 2.15 (nominal p
value ¼ 0.0157, D19S1034) and 1.95 (nominal p value ¼
0.0257, D19S921) in 125 families. D19S1034 and
D19S921 are separated by 73.7 cM andmight be considered
as markers of independent regions. Of the four ﬁne-map-The Aping regions, only chromosome 3q26 showed simulation-
based genome-wide signiﬁcance with an empirical p value
of 0.00055 (Table 2). The absence of simulation-based sig-
niﬁcance of chromosomes 11q22-q24, 18p11-q22, and
19p13-q13 does not rule out that genes that contribute to
the development of AGA are present at these loci. The rel-
evance of these regions for AGA susceptibility has to be in-
vestigated in larger samples.merican Journal of Human Genetics 82, 737–743, March 2008 739
In traits of complex inheritance, it is possible that two or
more genes contributing to the development of the dis-
ease are functionally connected and interact epistatically.
Figure 2. MOD-Score Analysis of Four
Chromosomes
Analysis of chromosomes 3, 11, 18, and 19
was performed in 95 families with early-
onset AGA. The multipoint LOD and NPL
scores are shown on the vertical axis, and
the distance (in cM, Duffy’s integrated
map) is given on the horizontal axis. Dot-
ted lines indicate LOD scores, and solid
lines indicate NPL scores.
We therefore tested our genome-scan
data for interaction between the X
chromosomal region containing the
AR gene locus and all autosomal loci.
We applied amultipoint nonparamet-
ric interaction analysis according to
the method described by Kong and
Cox,32 with the use of proportional
family weights.33 The procedure has
been described in detail elsewhere.34
In brief, the NPL score of a given fam-
ily at a given marker at the AR locus
was used as a weighting factor for
the same family, and a multipoint NPL analysis at an auto-
somalmarker locus was performed. Only families with NPL
scores greater than 0 at the AR locus were included for the
Figure 3. Fine-Mapping Linkage Analy-
sis of Four Chromosomal Regions
The multipoint NPL score is shown on the
vertical axis and the distance (top; in cM,
Duffy’s integrated map) and positions of
the fine-mapping STR markers (bottom)
on the horizontal axis. Dashed lines indi-
cate NPL scores of the genome scan, thin
lines indicate NPL scores of the fine-map-
ping marker set in families of the genome
scan, and thick lines indicate NPL scores
of the fine-mapping marker set in ex-
tended-family sample.
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Table 2. Multipoint NPL Fine-Mapping Analysis
NPL Score (Nominal p Value) Empirical p Valuec
Region and
Position [cM]a STR
Genome Scan,
95 Families
Fine Mapping,
95 Families
Fine Mapping,
125 Families
Fine Mapping,
125 Families
3q26
177.4 D3S3053 2.67 (0.0038) 2.58 (0.0049) 3.32 (0.0004) 0.00652
178.4 D3S1556b 3.14 (0.0004) 3.88 (0.00005) 0.00085
179.7 D3S2425b 3.02 (0.0012) 3.97 (0.00003) 0.00055
11q22
107.1 D11S1891b 2.55 (0.0055) 1.87 (0.0311) n.s.
109.2 D11S898 2.06 (0.0199) 2.22 (0.0132) 1.74 (0.0408) n.s.
18q11
44.6 D18S1104 2.5 (0.0063) 2.44 (0.0075) 1.97 (0.0244) n.s.
52.4 D18S877 2.3 (0.0109) 2.47 (0.0068) 1.90 (0.0291) n.s.
19p13
20 D19S1034 2.03 (0.0213) 1.93 (0.0273) 2.15 (0.0157) n.s.
93.7 D19S921 1.94 (0.026) 2.19 (0.0143) 1.95 (0.0257) n.s.
n.s. indicates not significant.
a Duffy’s integrated map.
b Not present in the genome-scan marker set.
c Genome-wide empirical p values based on 10,000 simulations.interaction linkage analysis at the autosomal markers. At
each autosomal marker of the genome, two NPL scores
were determined: one unweighted, called the baseline
NPL score, and one under the weighting scheme, called
the interaction NPL score. The difference between these
two NPL scores is termed DNPL score. To assess the signiﬁ-
cance of our interaction ﬁndings, we performed a permuta-
tion analysis. We randomly permuted the family weights
for the X chromosomal markers in the region of the AR
locus (eight markers) simultaneously to assess their contri-
butions to the interaction NPL scores. For each X chromo-
somal and autosomal marker combination, 10,000 per-
mutations were done, and for each combination, the
permutation was followed by the calculation of the differ-
ence between the interaction NPL scores and the original
NPL score (DNPL) under each weight. Permutation-based
NPL scores that exceeded those from the original weighting
procedure were counted and were then used for the deter-
mination of the signiﬁcance of the ﬁndings.
We foundno signiﬁcant evidence for interactionbetween
theAR locus and the autosomes for either the genome-wide
or the ﬁne-mapping data sets (Figure 4). This might suggest
that the AGA susceptibility genes in autosomal regions
showing evidence for linkage confer their risk through
pathways other than the classical androgen pathway. How-
ever, the power to detect interaction is limited because only
54–56 families were included in the analysis (based on their
NPL scores at theAR locus), and interaction cannot be ruled
out with the current data set. Regions on several chromo-
somes show DNPLs between 1 and 2, compatible with ef-
fects thatmight only be detectable in larger family samples.
The identiﬁcation of 14 regions with nominal evidence
of linkage reﬂects and supports the opinion that AGA is
caused by multiple genes. The data provide strong evi-
dence for the existence of an AGA susceptibility locus onThe A3q26. The 11.5 Mb core region with NPL scores greater
than 3 (ﬂanking STRmarkers D3S1763 and D3S3730) bears
34 reference sequence genes (University of California,
Santa Cruz genome browser, build 36) that will be the tar-
get of future association-based studies. Among the tran-
scripts are no genes known to be involved in hair biology,
and the best candidates might be genes which have been
implicated in AGA-associated diseases. The growth hor-
mone secretagogue receptor gene (GHSR), for example,
has been previously associated with obesity.35 Another in-
teresting candidate is TERC, which encodes the telomerase
RNA component. Mutations in TERC and the knockout of
the mouse homolog are well known to result in various
aging phenotypes.36–38 Because AGA is an age-correlated
trait, variability in genes modulating the process of aging
might have an impact on AGA susceptibility.
In contrast to the AR gene located on the X chromo-
some,27,28 the autosomal location of the AGA susceptibil-
ity loci of the present study might explain the resemblance
of fathers and sons with respect to the development
of AGA.15,16 Because AGA also occurs in females (female
pattern hair loss), future studies will need to investigate
whether the loci implicated in the present study have
a similar effect in affected females. In conclusion, our
data are the ﬁrst step toward the identiﬁcation of new
genes contributing to the development of early onset AGA,
a process which will contribute to the understanding of
human hair biology.
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